As you know, SMBG is a vital tool in the treatment and management of diabetes. To help you stay current on key research on SMBG, Bayer HealthCare has sponsored the Results That Matter webinar series. Throughout the series, SMBG specialists Bruce Bode, MD, and William Fisher, PhD, guide you on a highly informative journey through important data uncovered by recent studies on SMBG.
Session 1: Changing Testing Behavior to Change Results: Improving Diabetes Self-Management*
SMBG specialists Bruce Bode, MD, and William Fisher, PhD, provide a detailed analysis of the ACT* Study, which examined the use of the optional tracking features in the CONTOUR® meter from Bayer versus standard testing.1 An analysis of the behavioral survey included in the ACT study is also provided.2
Session 2: Understanding Effective Self-Monitoring of Blood Glucose
In the second part of the series, Drs Bode and Fisher review the requirements for successful SMBG, then cover topics including the assessment of SMBG adherence, the effect of behavioral interventions on SMBG, educating patients about SMBG, and clinical practice implications.
Session 3: Hows and Whys of SMBG Behavior Change
For the final part of the series, Drs Bode and Fisher offer further insights into SMBG from the perspective of FPG and PPG management; reducing the risk of microvasular and macrovascular complications; the relationship between A1C, FPG, and PPG; a sample patient case study with recommended treatment and self-care regimen; and much more.